Daito Pharmaceutical Co.,ltd. Ownership
¥1,350.00
0.00%
Tokyo, Sep 28, 03:30 pm JST.
ISIN
JP3486150000
Symbol
4577
Industry
Daito Pharmaceutical Co.,ltd. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Kaname Capital, L.P.
|
3.351m | 11.66% | +287.000k | Jul 31 2025 |
| 2 |
MFS Investment Management
|
1.177m | 4.10% | -185.080k | Jan 30 2026 |
| 3 |
Wang (Zhao)
|
1.000m | 3.48% | +168.200k | Nov 30 2025 |
| 4 |
KK Otsuga
|
800.600k | 2.79% | — | Nov 30 2025 |
| 5 |
Nomura Asset Management Co., Ltd.
|
749.689k | 2.61% | -71.500k | Mar 31 2026 |
|
1
Kaname Capital, L.P.
|
11.66%
3.351m
|
|
2
MFS Investment Management
|
4.10%
1.177m
|
|
3
Wang (Zhao)
|
3.48%
1.000m
|
|
4
KK Otsuga
|
2.79%
800.600k
|
|
5
Nomura Asset Management Co., Ltd.
|
2.61%
749.689k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 24.63% of Daito Pharmaceutical Co.,ltd., with Kaname Capital, L.P. the biggest at 11.66%, followed by MFS Investment Management (4.10%) and Wang (Zhao) (3.48%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
